{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T10:27:36Z","timestamp":1781000856893,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"German Federal Ministry of Education and Research","award":["01EO0802"],"award-info":[{"award-number":["01EO0802"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.bpg.2011.10.003","type":"journal-article","created":{"date-parts":[[2011,11,30]],"date-time":"2011-11-30T11:19:03Z","timestamp":1322651943000},"page":"741-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Medical and endoscopic therapy of primary sclerosing cholangitis"],"prefix":"10.1016","volume":"25","author":[{"given":"Tobias J.","family":"Weism\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim O.","family":"Lankisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpg.2011.10.003_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"Lindkvist","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1053\/j.gastro.2008.01.042","article-title":"The natural history of small-duct primary sclerosing cholangitis","volume":"134","author":"Bjornsson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib9","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bpg.2008.11.017","article-title":"Autoimmune pancreatitis and IgG4-associated sclerosing cholangitis","volume":"23","author":"Nishimori","year":"2009","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2011.10.003_bib11","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2008.01.020","article-title":"The challenges in primary sclerosing cholangitis\u2013aetiopathogenesis, autoimmunity, management and malignancy","volume":"48","author":"Weismuller","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib12","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1053\/j.gastro.2009.11.046","article-title":"Genome-wide association analysis in primary sclerosing cholangitis","volume":"138","author":"Karlsen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.728","article-title":"Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci","volume":"43","author":"Melum","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.bpg.2011.10.003_bib14","doi-asserted-by":"crossref","first-page":"e12403","DOI":"10.1371\/journal.pone.0012403","article-title":"Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis","volume":"5","author":"Hov","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bpg.2011.10.003_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.dld.2010.01.011","article-title":"Update on primary sclerosing cholangitis","volume":"42","author":"Karlsen","year":"2010","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.003_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bpg.2011.10.003_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2011.04.014","article-title":"Will we ever model PSC? \u2013 \u201cIt\u2019s hard to be a PSC model!\u201d","author":"Pollheimer","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.bpg.2011.10.003_bib19","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/j.1365-2036.2011.04658.x","article-title":"Systematic review: management options for primary sclerosing cholangitis and its variant forms \u2013 IgG4-associated cholangitis and overlap with autoimmune hepatitis","volume":"33","author":"Culver","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bpg.2011.10.003_bib20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","article-title":"Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis","volume":"3","author":"Beuers","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib21","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0168-8278(90)90281-U","article-title":"Ursodeoxycholic acid for primary sclerosing cholangitis","volume":"11","author":"Chazouilleres","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hep.1840160315","article-title":"Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial","volume":"16","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1056\/NEJM199703063361003","article-title":"Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group","volume":"336","author":"Lindor","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bpg.2011.10.003_bib24","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib25","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2007.12.023","article-title":"High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective","volume":"48","author":"Cullen","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib27","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bpg.2011.10.003_bib30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib31","unstructured":"Eaton JE, Silveira MG, Pardi DS, Sinakos E, Kowdley KV, Luketic VA, et\u00a0al. High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Am J Gastroenterol."},{"key":"10.1016\/j.bpg.2011.10.003_bib32","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MEG.0b013e3281108068","article-title":"The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid","volume":"19","author":"Rudolph","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib33","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib34","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20943","article-title":"Novel biotransformation and physiological properties of norursodeoxycholic acid in humans","volume":"42","author":"Hofmann","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib35","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1111\/j.1572-0241.2000.02323.x","article-title":"Oral budesonide in the treatment of primary sclerosing cholangitis","volume":"95","author":"Angulo","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib37","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/00365520310005172","article-title":"Long-term effect of corticosteroid treatment in primary sclerosing cholangitis patients","volume":"38","author":"Boberg","year":"2003","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib40","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2009.04.010","article-title":"Autoimmune pancreatitis\/IgG4-associated cholangitis and primary sclerosing cholangitis\u2013overlapping or separate diseases?","volume":"51","author":"Webster","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib41","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2007.12.009","article-title":"Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy","volume":"134","author":"Ghazale","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib42","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.23835","article-title":"Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis","volume":"52","author":"Asrani","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2010.10.044","article-title":"Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis","author":"Patsenker","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib44","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1186\/1471-2407-10-631","article-title":"Targeting EGFR\/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas","volume":"10","author":"Pignochino","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bpg.2011.10.003_bib45","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1158\/1078-0432.CCR-07-0738","article-title":"Activated mammalian target of rapamycin is an adverse prognostic factor in patients with biliary tract adenocarcinoma","volume":"13","author":"Herberger","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bpg.2011.10.003_bib46","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0016-5085(90)90833-M","article-title":"Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth","volume":"98","author":"Lichtman","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib47","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers","volume":"28","author":"Olsson","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.gie.2010.02.043","article-title":"Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis","volume":"72","author":"Negm","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2011.10.003_bib49","first-page":"1504","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis\u2013a study of bile cultures from ERCP","volume":"47","author":"Bjornsson","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.bpg.2011.10.003_bib50","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/hep.20457","article-title":"Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial","volume":"40","author":"Farkkila","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ajg.2008.14","article-title":"Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study","volume":"104","author":"Silveira","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib52","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","article-title":"Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic","volume":"47","author":"Davies","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.bpg.2011.10.003_bib53","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00535-006-1891-1","article-title":"Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats","volume":"41","author":"Ueki","year":"2006","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/labinvest.2010.162","article-title":"beta-Adrenoceptor blockade in sclerosing cholangitis of Mdr2 knockout mice: antifibrotic effects in a model of nonsinusoidal fibrosis","volume":"91","author":"Strack","year":"2011","journal-title":"Lab Invest"},{"key":"10.1016\/j.bpg.2011.10.003_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12016-008-8085-y","article-title":"Medical treatment of primary sclerosing cholangitis: a role for novel bile acids and other (post-)transcriptional modulators?","volume":"36","author":"Beuers","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bpg.2011.10.003_bib56","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00535-010-0204-x","article-title":"Bezafibrate for the treatment of primary sclerosing cholangitis","volume":"45","author":"Mizuno","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1023\/A:1026673811278","article-title":"Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study","volume":"44","author":"Angulo","year":"1999","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.10.003_bib58","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1111\/j.1572-0241.2000.02324.x","article-title":"A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis","volume":"95","author":"Bharucha","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e3282f5197e","article-title":"Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study","volume":"20","author":"Vleggaar","year":"2008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib60","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1007\/s10620-007-0052-6","article-title":"Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study","volume":"53","author":"Angulo","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.bpg.2011.10.003_bib61","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2006-933564","article-title":"Primary sclerosing cholangitis: the role of endoscopic therapy","volume":"26","author":"Stiehl","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bpg.2011.10.003_bib62","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1477-2574.2010.00268.x","article-title":"Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis","volume":"13","author":"Aljiffry","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.bpg.2011.10.003_bib63","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gie.2009.10.041","article-title":"Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment","volume":"71","author":"Gotthardt","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2011.10.003_bib64","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/00365520701206761","article-title":"Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"42","author":"Tischendorf","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib67","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"38","author":"Tischendorf","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2011.10.003_bib68","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/hep.24103","article-title":"Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis","volume":"53","author":"Lankisch","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.bpg.2011.10.003_bib69","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1055\/s-2000-7708","article-title":"Prospective risk assessment of endoscopic retrograde cholangiography in patients with primary sclerosing cholangitis. Dutch PSC Study Group","volume":"32","author":"van den Hazel","year":"2000","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2011.10.003_bib70","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ajg.2008.161","article-title":"Complications of endoscopic retrograde cholangiopancreatography in primary sclerosing cholangitis","volume":"104","author":"Bangarulingam","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","article-title":"The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis","volume":"18","author":"Pohl","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bpg.2011.10.003_bib72","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.bpg.2011.10.003_bib73","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1097\/MCG.0b013e3181646713","article-title":"A twenty-year experience with endoscopic therapy for symptomatic primary sclerosing cholangitis","volume":"42","author":"Gluck","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib74","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/j.1572-0241.2001.03690.x","article-title":"Balloon dilation compared to stenting of dominant strictures in primary sclerosing cholangitis","volume":"96","author":"Kaya","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib75","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1111\/j.1572-0241.1999.01364.x","article-title":"Four years experience with short term stenting in primary sclerosing cholangitis","volume":"94","author":"Ponsioen","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bpg.2011.10.003_bib76","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1572-0241.2006.00383.x","article-title":"Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?","volume":"101","author":"Awadallah","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 1","key":"10.1016\/j.bpg.2011.10.003_bib77","first-page":"S69","article-title":"Endoscopic management of bile duct stones","volume":"22","author":"Itoi","year":"2010","journal-title":"Dig Endosc"},{"key":"10.1016\/j.bpg.2011.10.003_bib78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2007-1005552","article-title":"Endoscopic management of biliary tract strictures in primary sclerosing cholangitis","volume":"28","author":"Wagner","year":"1996","journal-title":"Endoscopy"},{"key":"10.1016\/j.bpg.2011.10.003_bib79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1148\/radiology.170.1.2462261","article-title":"Sclerosing cholangitis: palliation with percutaneous cholangioplasty","volume":"170","author":"Skolkin","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.bpg.2011.10.003_bib80","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1159\/000177017","article-title":"ERCP with the balloon-assisted enteroscopy technique: a systematic review","volume":"26","author":"Koornstra","year":"2008","journal-title":"Dig Dis"}],"container-title":["Best Practice & Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691811000916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:00:48Z","timestamp":1761498048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691811000916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":80,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S1521691811000916"],"URL":"https:\/\/doi.org\/10.1016\/j.bpg.2011.10.003","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medical and endoscopic therapy of primary sclerosing cholangitis","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpg.2011.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}